News

UnitedHealth (NYSE: UNH) is capturing headlines for all the wrong reasons.

*Stock prices used were the afternoon prices of May 13, 2025. The video was published on May 15, 2025.

Continue reading

So

Looking for income? You might want to check out Pfizer (NYSE: PFE). This big drugmaker has been a favorite for income investors for years. However, its dividend is arguably more attractive than

Healthcare insurance giant UnitedHealth Group (NYSE: UNH) has seen its stock go from a stable stalwart to a falling knife, seemingly overnight. The stock's price crashed 22.4% on April 17 in

If you're looking to boost your passive income, Coca-Cola (NYSE: KO) and AT&T (NYSE: T) are solid dividend stock choices right now. These companies generate repeat revenue from consumers throughout

Over the past year, America's typically predictable health insurance industry has been exciting in ways that investors hardly appreciate. In a nutshell, healthcare expenses have been outpacing the

Shares of UnitedHealth Group (NYSE: UNH) are falling on Thursday. The company's stock has plummeted 15% as of 11:33 a.m. ET but lost as much as 19.2% earlier in the day. The collapse comes as the

In this video, I will cover the recent updates regarding Advanced Micro Devices (NASDAQ: AMD), Nvidia, and Intel. Watch the short video to learn more, consider subscribing, and click the special

Recently, the Trump Administration signed an executive order to lower the prices Americans pay for prescription drugs. According to the administration, the U.S. funds roughly 75% of global

Explore the exciting world of Axsome Therapeutics (NASDAQ: AXSM) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market

Shares of Exelixis (NASDAQ: EXEL) were skyrocketing 18.5% higher at 11:05 a.m. ET on Wednesday. The huge gain came after the drugmaker announced its 2025 first-quarter results Tuesday evening.

It's no secret that President Donald Trump is heavily invested in cryptocurrencies ranging from Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO: ETH) to his Official Trump (CRYPTO: TRUMP) meme coin on

Makers of weight-loss drugs, the hottest segment of the pharmaceutical market just now, weren't looking so hot on the stock exchange Tuesday. A pronouncement from President Trump about the category

In today's video, I discuss recent updates impacting Advanced Micro Devices (NASDAQ: AMD) and Nvidia (NASDAQ: NVDA) after Taiwan Semiconductor Manufacturing (NYSE: TSM) reported its monthly revenue

Investing in promising companies before their stock prices soar is an excellent recipe for earning life-changing returns. However, with hundreds of companies vying for investors' attention

Vertex Pharmaceuticals (NASDAQ: VRTX), a leading drugmaker, is performing exceedingly well for the year -- or at least it was, until it released its first-quarter update. The results were not to the

Fundamental investing wisdom tells us to buy stocks with potential when they are trading at a lower valuation. But when a company's prospects look dim, its stock isn't going to be attractive even

Monday wasn't a very good day for health insurers, and if a day's not good for health insurers you can bet Cigna Group (NYSE: CI) stock took it on the chin.

The blow came from the highest levels of

Investors and consumers have been climbing a wall of worry lately. The imposition of tariffs and the trade war with China has sparked concerns about the potential to reignite inflation and pressure

Regardless of how stocks are performing right now, history tells us that the market tends to generate solid returns over long periods. Investors can do even better than the average market

Income investors have liked Pfizer (NYSE: PFE) for years. However, the big drugmaker's exceptionally juicy dividend these days has made its stock even more attractive.

But when a dividend yield